Characterizing the Transformation and Diagnosis of Atypical Lipomatous Tumor to Dedifferentiated Liposarcoma: Single Institutional Outcomes
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.27924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Zachary Butler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Division of Oncology, Rush University Medical Center, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Liposarcoma, Lipoma, Cell Transformation, Neoplastic, Extremities. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
Atypical lipomatous tumor (ALT) in the extremities is a locally aggressive adipocytic tumor with the potential risk of transformation into dedifferentiated liposarcoma (DDLS). Studies seldom differentiate whether DDLS was diagnosed on initial biopsy, final resected specimen, or subsequent recurrence. Our study seeks to characterize how and when patients received their ALT or DDLS diagnoses to better understand the relationship between the two neoplasms.
Methods
We performed a retrospective review of patients diagnosed with ALT or DDLS of the extremities. Clinical characteristics, including the method of diagnosis of an ALT or DDLS, time between diagnoses, and tumor recurrence was recorded. Univariate/multivariate analysis was performed to identify risk factors.
Results
Forty‐five patients were diagnosed with ALT after core needle biopsy (CNB) and 41 of them received marginal en bloc excision. Three (7.3%) of these patients had a heterogeneous tumor on final resection, pathology revealed both ALT and DDLS. Four patients (8.2%) were diagnosed with DDLS from CNB and received negative margin en bloc excision. One of these tumors was identified as heterogeneous ALT/DDLS after resection. Fifty‐three patients received marginal en bloc resection without CNB after a benign lipomatous mass was suspected on CT/MRI. Among these, one (1.9%) had a tumor with a heterogeneous composition of both ALT and DDLS on pathology. There were 11 (11.7%) ALT recurrences and 1 (1.0%) DDLS recurrence after ALT resection.
Conclusion
Obtaining a proper diagnosis whether ALT or DDLS is critical. Our cohort found that amongst those concerning lipomatous lesions biopsied, 7.84% will show biopsy proven DDLS. Additionally, 6.67% of the biopsies will be false negatives and show DDLS on final pathology. Furthermore, our local recurrence for ALT was 11.7% recurring as ALT and 1.0% recurring as DDLS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Division of Oncology, Rush University Medical Center, Chicago, Illinois, USA.
- Rush Medical College, Chicago, Illinois, USA.
- Department of Pathology, Rush University Medical Center, Chicago, Illinois, USA.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Butler, Z., Yu, A., Honore, L., Timmermann, A., Demetrious, M., Gitelis, S., Miller, I., & Blank, A. (2025). Characterizing the Transformation and Diagnosis of Atypical Lipomatous Tumor to Dedifferentiated Liposarcoma: Single Institutional Outcomes. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27924
Vancouver
Butler Z, Yu A, Honore L, Timmermann A, Demetrious M, Gitelis S, et al. Characterizing the Transformation and Diagnosis of Atypical Lipomatous Tumor to Dedifferentiated Liposarcoma: Single Institutional Outcomes. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27924
BibTeX
@article{Butler2025,
author = {Butler, Zachary and Yu, Austin and Honore, Lesly and Timmermann, Anne and Demetrious, Matthew and Gitelis, Steven and Miller, Ira and Blank, Alan},
title = {Characterizing the Transformation and Diagnosis of Atypical Lipomatous Tumor to Dedifferentiated Liposarcoma: Single Institutional Outcomes},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.27924}
}
EUVIMED